Asianet Newsable on MSN
HIMS stock slips overnight after FDA staff questions safety of popular peptides — but one analyst says 'this isn't the end'
The FDA staff’s view clashes with RFK Jr.’s push to deregulate peptides and move more of them toward Category 1 status.
The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by ...
During the second meeting of the US Food and Drug Administration’s (FDA) Digital Health Advisory Committee (DHAC), members of the panel seemed shocked and, at times, lost for words when grappling with ...
The mHealth Regulatory Coalition (MRC) recently released “A Call for Clarity: Open Questions on the Scope of FDA Regulation of mHealth," which is a 60-page paper that focuses on two fundamental ...
Retatrutide, a new weight-loss drug, has yet to be approved by the U.S. Food and Drug Administration (FDA). But according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results